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1078–5Objectives. To assess the extent of discrepancies between different vascular registries, at various levels of validation, and to
investigate whether such differences might alter the morbidity and mortality rates obtained from the gold standard dataset
for carotid endarterectomy (CEA).
Methods. All CEA operations in Helsinki University Central Hospital from 2000e2005 were retrieved from the local vas-
cular registry (HUSVASC) and the Hospital Discharge Registry (HILMO). Both registries were validated at different
levels to form the final dataset. Total and indication-specific perioperative morbidity and mortality rates were estimated
from each level of validation and compared with those from the final dataset and with pooled rates from systematic reviews.
Results. Initial search provided 675 and 681 CEAs from HUSVASC and HILMO, respectively, decreasing to 636 (94%)
and 614 (90%) when using the specific operative codes for thrombendarterectomy and patch angioplasty. Manual verifi-
cation of initial HUSVASC results proved that 655 (97%) operations were true CEAs. 18 further proven CEAs, registered
only in HILMO, were added to form the final CEA dataset (n¼ 673). The peri-operative morbidity and combined morbid-
ity and mortality rates were 2.23% and 2.67%, respectively. Comparable rates were obtained from both registries, irrespec-
tive the level of verification.
Conclusion. Registry data do not appear to be biased by random loss of some operations and thus they are reliable for
decision-making. However, further research is still needed to estimate the permissible volume of omissions in a registry
for the data-base to remain trustworthy.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The beneficial role of carotid endarterectomy (CEA) in
stroke prevention has been demonstrated by the large
randomized clinical trials, in groups with different in-
dications. Individual hospital operative morbidity
and mortality levels should be monitored and not ex-
ceed the levels defined levels from randomised trials
and their critical reviews.1e8 Therefore, the process
of data collection, monitoring, and reporting is man-
datory after CEA at the institutional as well as
surgeon-specific levels. Large meta-analyses and sys-
temic reviews depend upon the reliability of their
data.9 However, various types of data enhancement
may bias registry data. It is generally accepted thatsponding author. P. Vikatmaa, MD, Helsinki University Cen-
spital, Department of Surgery, Division of Vascular Surgery,
x 340 FI-00029 HUS, Finland.
address: pirkka.vikatmaa@hus.fi
884/000280+ 06 $34.00/0  2007 European Society for Vascularegistry data yield smaller complication figures than
prospective series and randomised trials.10
In thepresent study, our aimwas todetermine the in-
clusiveness of different registries used for routine pa-
tient data collection, the extent of differences between
them, and specifically whether these registries give
comparable morbidity and mortality rates for CEA.Methods
The Department of Vascular Surgery in Helsinki Uni-
versity Central Hospital (HUCH) employs two differ-
ent registries for collecting the patient clinical data:
the local vascular registry, HUSVASC, which is sup-
ported by HUCH; and the nationwide Hospital Dis-
charge Registry (HILMO), which is maintained by
the National Research and Development Centre for
Welfare and Health (STAKES), Finland.
HUSVASC was designed mainly to collect data of
vascular surgical interest from the routine medicalr Surgery. Published by Elsevier Ltd. All rights reserved.
Fig. 1. Number of CEAs retrieved from HUSVASC (2000e
2005) using different search criteria.
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dovascularly. HUSVASC employs FINNVASC dataset
is an extended version of the original presented by
Finnvasc Study Group.11 HUSVASC data is collected
prospectively with emphasis on all complications.
HILMO is intended for the national-specific medi-
cal and statistical purposes, and requires all operative
codes and treatment episodes to be recorded. There-
fore, HUSVASC gives more information about the
patients’ medical history, medication, risk factors,
pre-operative investigations, indications of surgery,
operative details, and complications. On the other
hand, HILMO principally includes all operated pa-
tients and allows access to any treatment episode ne-
cessitated by later complications caused by surgery,
irrespective of the institution where the patient has
been treated.
To identify CEA operations from HUSVASC, oper-
ative anatomy, indication of operation (stroke, tran-
sient ischaemic attacks, amaurosis fugax, and
asymptomatic stenosis), or the related operative co-
des can be used. The same nationwide operative co-
des used both in HUSVASC and HILMO were
retrieved from NOMESCO (Nordic-Medico-Statistical
Committee) including codes for thrombendarterec-
tomy, patch angioplasty, and graft interposition
(PAF, PAN, and PAH, respectively) of the internal,
external, or common carotid arteries (codes 12, 13,
or 14, respectively). However, running a search using
a single search criterion may miss those CEAs for
which this particular data-field has not been com-
pleted or was miscoded by the treating surgeon.
Therefore, we used combined search criteria to track
any missing CEAs in the period from 2000 through
2005. We assumed that this combined search tracked
all CEAs. All inconsistent data were crosschecked
against patients’ records. Incorrect inclusions were
discarded manually.
Since the software design for both registries was
different, it was impossible to use a single method
for both datasets. Nevertheless, the operative codes
could still be used for CEA tracking in HILMO. To
find all the incorrectly coded CEAs, we searched
HILMO for any surgical or urgent endovascular inter-
vention to the aortic arch and its branches in the same
period (2000e2005).
Results of CEA from both registries were validated
and cross-matched at different levels against each
other using a personal identity code, which is unique
for every Finnish citizen. Therefore, all deficient or
faulty registrations in HUSVASC were added and
corrected.
Cases of carotid stenting were excluded, since in
Helsinki stenting is used only in specific indicationsreported in the first consensus document of the
ICSS-SPREAD Joint Committee.12
To assess the ability of the different registries to
give comparable rates of morbidity and mortality,
we searched both registries at the different levels of
verification for the prospectively collected major
strokes and fatal events within 30 days after CEA in
the period from 2000 to 2005. Results were stratified
according to the indication of the operation and com-
pared to those from the completed HUSVASC dataset.
Specific codes for postoperative complications (ICD-9
code 997.x and ICD-10 codes Y65, Y69, Y83, and Y88.x)
also were searched to ascertain postoperative mortal-
ity and morbidity.Results
Searching HUSVASC for CEAs offered a different re-
sult with each search criterion within the same time
range (2000e2005). The greatest number of CEAs
(HUSVASC-initial, n¼ 675) was obtained using these
combined criteria (Fig. 1). Out of these, 518 (71%)
and 118 (23%) were thrombendarterectomy and patch
angioplasty of the ICA, respectively, while the remain-
ing 39 (6%) were interposition grafts from the internal
or common carotid arteries, thrombendarterectomy of
the external or common carotid arteries, or incorrectly
coded or uncoded operations (Fig. 2a).
Verification of these operations demonstrated that
only 655 (97%) were true CEAs (HUSVASC-manual)
while the remaining 20 were unrelated surgical proce-
dures (Table 1). Further inspection of the verified
CEAs showed that 617 (94%) operations were per-
formed for symptomatic stenoses, mainly stroke 273
(41.7%) and transient ischaemic attack 218 (33.4%),
while only 35 (5.3%) CEAs were performed for
asymptomatic stenoses.Eur J Vasc Endovasc Surg Vol 35, March 2008
Fig. 2. Frequency of the operative codes of the unverified CEAs registered in (a) HUSVASC and (b) Hospital Discharge Reg-
istry HILMO (2000e2005).
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terectomies (PAF14-coded, 518; 79%) and all patch an-
gioplasties (PAN14-coded, 118; 18%) in the initial
HUSVASC search. The remaining 19 (3%) were
CEAs that ended with graft interposition, or were mis-
coded or uncoded (Table 1). The use of the NOMESCO
coding system in HUSVASC had a sensitivity and
specificity for CEA of 99.8% and 54.3%, respectively.
From HILMO (HILMO-initial) in the same period
(2000e2005), we retrieved 681 operations on the aortic
arch and its branches, most of which were thromben-
darterectomy (575; 84%) and patch-angioplasty (39;
5.7%) of the ICA (Fig. 2b).
Cross-matching the initial results from the two da-
tasets (681 in HILMO against 675 in HUSVASC)
showed that 640 CEAs were registered in both; 35
were included only in HUSVASC versus 41 recorded
in HILMO only (Fig. 3). To determine the reasons
for missing ‘‘assumed’’ CEAs from HUSVASC, we
checked the patients’ casenotes. Out of the 41 opera-
tions; 12 (29%) were not CEA operations, 10 (24%)
were registered but without any medical data, 6
(15%) were entirely unregistered, 6 (15%) were miss-
ing some key-data such as anatomy or indication forTable 1. Verification of the different operative codes of CEAs reg-
istered in HUSVASC (2000e2005)
Code No. of operations Proved CEA Non-CEA
PAF14 518 518 0
PAN14 118 118 0
PAF13 1 0 1
PAF12 4 4 0
PAH14 12 11 1
PAH12 8 1 7
Miscellaneous 13 2 11
Uncoded 1 1 0
Total 675 655 20
Eur J Vasc Endovasc Surg Vol 35, March 2008the operation, 2 (5%) had incorrect operative codes
and in the remaining 5 cases we could not identify
any reason.
Although the frequency of patch-angioplasty of
ICA was much lower in the initial results of HILMO
than in HUSVASC (6% vs. 23%), the rate of graft inter-
position originating from the ICA (PAH14-coded op-
erations) in HILMO was more than double the
corresponding rate in HUSVASC (5% vs. 2%). Further
scrutiny of the 37 PAH14-coded operations in HILMO
proved that only 5 (14%) operations were correctly
coded: almost half of them (18) were patch angio-
plasty and one third (12) were thrombendarterectomy
of the ICA, 1 was miscoded and 1 could not be
verified.
Operative codes PAF14 and PAN14, the two most
specific codes for CEA, comprised the majority of
the initial CEA results in both datasets (94% for HUS-
VASC and 90% for HILMO). Cross matching the 636
operations coded as PAF14 or PAN14 in HUSVASC
(HUSVASC-codes) against the corresponding 614 inFig. 3. Cross-matching of the unverified CEA results from
HILMO against HUSVASC (2000e2005).
283Registries Reliability after Carotid EndarterectomyHILMO (HILMO-codes) showed that 592 operations
were available in both sets, 44 in HUSVASC only
and 22 were missing from HUSVASC-codes (Fig. 4).
To find all the CEAs missing from the manually
proven HUSVASC dataset, we compared it against
HILMO initial results. This yielded 34 missing opera-
tions from HUSVASC-manual, 18 of which proved to
be true CEAs and consequently were added to the
HUSVASC-manual list to form the completed and
confirmed HUSVASC (HUSVASC-complete, n¼ 673)
dataset.
According to the final dataset, the perioperative
mortality, morbidity, and combined morbidity and
mortality rates are 0.5%, 2.2%, and 2.7%, respectively.
Stratification of these results by indication for surgery
showed that stroke patients had the highest rates of
morbidity and combined morbidity and mortality
(3.2% and 3.9%, respectively). The rates in TIA pa-
tients (both1.8%) and amaurosis fugax patients (mor-
bidity and combined morbidity and mortality rates of
1.8% and 2.3%, respectively) were much lower. None
of the asymptomatic patients suffered a perioperative
stroke or death (Table 2).
In addition, both registries, irrespective the com-
pleteness of data provided comparable rates of mor-
bidity and combined morbidity and mortality. Yet,
stratification of these rates according to the indica-
tion of operation showed greater differences be-
tween datasets, particularly for stroke rates (Table
2). Using codes for postoperative central nervous
system complications available in the ICD coding
systems (ICD-9 code 997.x and ICD-10 codesY65,
Y69, Y83, and Y88.x) in the entire registry of
HUCH yielded 38 patients, but none of them had
undergone CEA.Fig. 4. Schematic diagram shows levels of cross-matching and n
registries (2000e2005).Discussion
Carotid endarterectomy is a prophylactic operation
that typically does not have any direct effect a patient
can perceive immediately after surgery. It remains in-
dicated to prevent stroke or stroke recurrence espe-
cially in symptomatic patients with tight stenosis,
among whom, the number needed to prevent one
stroke or death within the following 5 years is 5e6 de-
pending on individual series.8,12,13 Outcome analysis
is obligatory to justify the procedure, as the benefit
from the operation decreases as operative morbidity
and mortality increase.
There is a large body of data to suggest that the low
morbidity and mortality rates, which dominate the lit-
erature on the results of surgical treatment of carotid
stenosis, are better than average and represent se-
lected series.13 Surgical registries might have better in-
formation for population-based results, although their
data are not without biases either, as shown by early
experience with Finnish Vascular Registries
FINNVASC.14,15
In southern Finland, where HUCH has its own
catchment area of 1.4 million people for carotid sur-
gery, two registries with different purposes and de-
signs are utilized. While HUSVASC is the vascular
oriented registry, voluntarily maintained for quality
control and professional interests, is completed as
part of hospital routine, HILMO is mandatory and
benefits from the broader nationwide patients’ cover-
age, as well as supporting financial and human re-
sources. In addition, the pooled data from HILMO
can provide information on a national basis, to inform
epidemiological studies and planning for the national
medical strategies. Neither of them can be consideredumbers of CEA operations between HUSVASC and HILMO
Eur J Vasc Endovasc Surg Vol 35, March 2008
Table 2. Comparison of two different patient registries with data for carotid endarterectomy in Department of Vascular Surgery,
Helsinki University Central Hospital 2000e2005
HUSVASC HILMO
HUSVASC-codes
(PAF14þ PAN14)
HUSVASC-manual
(confirmed
incomplete)
HUSVASC-
initial
HUSVASC-
complete
HILMO-codes
(PAF14þ PAN14)
HILMO-
initial
CEAs 636 655 675 673 614 681
% % % % % %
Indication
Symptomatic 600 94.3 621 94.8 618 91.6 637 94.7 NA NA NA NA
Stroke 266 41.8 274 41.8 273 40.4 280 41.6 174 28.3 185 27.2
TIA 213 33.5 220 33.6 219 32.4 227 33.7 304 49.5 326 47.9
AFX 121 19.0 127 19.4 126 18.7 130 19.3
Asymptomatic 33 5.2 34 5.2 38 5.6 36 5.4
Unknown 3 0.5 0 0.0 19 2.8 0 0.0 136 22.2 170 25.0
Robust outcome measures
Op. Mortality 2 0.3 3 0.5 4 0.6 3 0.5 2 0.3 4 0.6
Op. Morbidity 15 2.4 15 2.3 15 2.2 15 2.2 15 2.4 15 2.2
M&M 17 2.7 18 2.6 19 2.8 18 2.7 17 2.8 19 2.8
Morbidity stratified by indication
Symptomatic 15 2.5 15 2.4 15 2.4 15 2.4 NA NA NA NA
Stroke 9 3.4 9 3.3 9 3.3 9 3.2 8 4.6 8 4.3
TIA 4 1.9 4 1.8 4 1.8 4 1.8 0 0 0 0
AFX 2 1.7 2 1.6 2 1.6 2 1.5
Asymptomatic 0 0.0 0 0.0 0 0.0 0 0.0
Unknown 0 0.0 0 0.0 0 0.0 0 0.0 7 5.2 7 4.1
Combined morbidity and mortality stratified by indication
Symptomatic 17 2.8 18 2.9 18 2.9 18 2.8 NA NA NA NA
Stroke 10 3.8 11 4.0 11 4.0 11 3.9 9 5.2 9 4.9
TIA 4 1.0 4 1.8 4 1.8 4 1.8 0 0 0 0
AFX 3 2.5 3 2.4 3 2.4 3 2.3
Asymptomatic 0 0.0 0 0.0 0 0.0 0 0.0
Unknown 0 0.0 0 0.0 1 5.3 0 0.0 8 5.9 10 5.9
AFX, amaurosis fugax.
284 A. G. Taha et al.the ‘‘gold standard’’ registry as both may be lacking
some procedures, patients, or other data. Neverthe-
less, the availably of more than one registry and
a unique personal identity code for every Finnish cit-
izen, facilitated the process of their validation and
crosschecking against each other.
The key question with any registry data is not what
percentage of the patients is missing, as it is inevitable
that some patients are missed, but whether omissions
from registery skew morbidity and mortality rates af-
ter CEA. Initial HUSVASC search was able to cover
97% of CEAs. This compares favourably with the total
inclusion of 91% or 96% in Swedvasc, 81% in Finnvasc
and 84% in NorKar.15e18 It should be noted that the
figures in previous registry validations were not fully
cross matched on an individual level with their
respective comparison registries, due to legal
restrictions.17e19
Reviewing all major strokes and deaths within 30
post-CEA days showed minimal differences in mor-
bidity and combined morbidity and mortality rates
within the different levels of each registry or betweenEur J Vasc Endovasc Surg Vol 35, March 2008both registries, including the final verified dataset.
Yet, some differences between datasets, particularly
for stroke rates, were observed. As mortality was
low, one unregistered death may affect the mortality
rate markedly.
Stratification of morbidity and mortality according
to the indication for surgery had similar effect within
the each dataset, irrespective of its completeness, but
the greatest difference between data sets was for
stroke rates.
The differences were minimal between registries,
which allow either of them, if scrutinized properly,
to be used for the identification of complication rates.
However, the specific vascular registry allows more
detailed analysis according to indication for sur-
gery.20,21 The complication rates were within the
acceptable range, both overall and within each indica-
tion category as suggested by the Ad Hoc Committee
of the AHA Stroke Council22 (Table 3). In addition, the
registry results for the mortality, morbidity, and com-
bined morbidity and mortality rates compare favour-
ably with those reported in a recent meta-analysis9 of
Table 3. Pooled data and local levels of absolute risk of stroke and
death compared with the recommended acceptable standards for
morbidity and mortality, according to the indication for carotid
endarterectomy
Pooled (%) Local (%) Recommended* (%)
Symptomatic 5.1 2.8 <6
 Stroke 7.1 3.9 <7
 TIA 5.5 1.8 <5
 AFX 2.8 2.3
Asymptomatic 2.8 0.0 <3
AFX, amaurosis fugax.
Pooled data of 38338 CEA operations (ref 17), recommendation
(ref 18,19).
* Mortality should not exceed 2% (ref 18,19).
285Registries Reliability after Carotid Endarterectomy25 studies comprising 935156 CEA operations (0.5%,
2.2%, and 2.7% in the present study versus 1.6%,
2.7%, and 4.3% in the meta-analysis). Furthermore,
stroke was the most common indication in the present
series.
The present data showed that there were not major
differences between the two registries used, even at
different levels of validation. It also showed that over-
all and indication-specific perioperative morbidity
and mortality rates after CEA compared favourably
to the figures reported from major randomized trials
or the recent systematic reviews and meta-analyses.
However, this study also revealed that postoperative
complication codes of ICD-9 or ICD-10 coding sys-
tems were not used for carotid complications in our
hospital. This emphasizes the importance of scrutiniz-
ing registry data and maintaining quality control us-
ing a random data sample from time to time as
previously suggested.15e19
In conclusion, registry data appear not to be biased
by missing cases with poor outcomes. Therefore regis-
tries can provide valuable information for decision-
making. How much missing data can be tolerated
remains an unanswered question.References
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